Origin Therapeutics Holdings Inc.
Origin is an investment issuer that has historically focused on making equity investments in psychedelics-industry-related companies to provide investors with diverse exposure to the sector. On December 8, 2022, the Company announced that its board of directors had initiated a review process to consider, review and evaluate strategic alternatives for the Company.
Origin Therapeutics Holdings Inc. (ORIG)
le juin 2/June 2022
The common shares of Origin Therapeutics Holdings Inc. have been approved for listing on the CSE.
Listing and disclosure documents will be available at www.thecse.com on the trading date.